期刊文献+

AML-M1相关TCR Vβ克隆性增殖T细胞的研究 被引量:7

Analysis of clonal expansion of TCR Vβ subfamily T cells associated with AML-M1
下载PDF
导出
摘要 目的 了解急性髓细胞白血病M1亚型 (AML M1 )患者外周血TCRVβ亚家族T细胞的克隆性分布特点。 方法采用RT PCR扩增 9例M1患者外周血的单个核细胞的TCRVβ2 4个亚家族基因 ,分析其TCRVβ亚家族的利用情况。PCR产物进一步经基因扫描分析 ,了解其CDR3长度以判断T细胞的克隆性。结果 不同标本中可检测到 2~ 5个Vβ亚家族T细胞 ,以Vβ2、Vβ3、Vβ1 7和Vβ1 9为常见 ,并在Vβ2、Vβ3、Vβ5、Vβ8、Vβ9和Vβ1 9中发现克隆性生长T细胞。结论 M1病人外周血TCRVβ亚家族T细胞表达呈现明显的选择性和克隆性增殖情况 ,这可能与M1细胞相关抗原有关 ,且克隆性增殖Vβ亚家族分布以个体特异性为主。 Objective To investigate the distribution and clonality of TCR Vβ subfamily T cells in patients with M1 subtype of acute myelogenous leukemia (AML M1). Methods The CDR3 size of TCR Vβ 24 subfamily genes was amplified in peripheral blood mononuclear cells from 9 cases with AML M1 using RT PCR, to observe the usage of TCR Vβ repertoire, the PCR products were further analyzed by gene scan technique for detection of the CDR3 size, to evaluate clonality of TCR Vβ T cells.Results 2~5 Vβ subfamily T cells could be identified from different samples in M1 cases, predominantly in Vβ2,3,17 and 19. Oligoclonal (clonal expansion) T cells were identified in Vβ2, 3, 5, 8, 9 and 19 subfamilies.Conclusions The selected usage and clonal expansion of TCR Vβ subfamily T cells from peripheral blood could be found in patients with M1, it may be related to M1 associated antigen. Distribution of Vβ subfamily clonal expansion displays individual specificity.
出处 《免疫学杂志》 CAS CSCD 北大核心 2002年第5期353-355,359,共4页 Immunological Journal
基金 国家自然科学基金 (39870 358) 广东省的研究自然科学基金 (980 70 5) 广州市科委重点科技攻关计划 (98 z 0 39 0 1 ) 广东省医学科研基金 (A1 9992 71 )资助项目
关键词 TCR VΒ基因 T细胞克隆性 急性髓细胞白血病 RT-PCR 基因扫描 TCR Vβ gene T cell acute myelogenous leukemia RT PCR genescan
  • 相关文献

参考文献3

二级参考文献12

  • 1Chen Z,Genes Chromosomes Cancer,1998年,22卷,321页
  • 2李扬秋,中国免疫学杂志,1998年,14卷,48页
  • 3李扬秋,肿瘤,1997年,17卷,435页
  • 4Gorski J,J Immunol,1994年,152卷,5109页
  • 5李扬秋,中国免疫学杂志,1998年,14卷,48页
  • 6李扬秋,肿瘤防治研究,1998年,25卷,23页
  • 7Bocchia M,Blood,1996年,87卷,3587页
  • 8Liu D,J Immunol Method,1995年,187卷,139页
  • 9Wilson R K,Immunol Rev,1988年,101卷,1期,149页
  • 10李扬秋,汪明春,SiegertW,SchmidtCA.利用 Genescan 分析 TCRVβ 亚家族CDR3长度的方法检测AML的T细胞克隆性[J].肿瘤,1997,17(6):435-438. 被引量:24

共引文献22

同被引文献64

  • 1耿素霞,李扬秋,杨力建,陈少华,韩素芳,周羽竝,陈青山.实时定量PCR分析CML患者胸腺近期输出功能[J].肿瘤防治研究,2004,31(6):317-319. 被引量:10
  • 2李扬秋,杨力建,陈少华,周羽竝,耿素霞秋,陈青山.AML-M5患者外周血naiveT细胞水平和TCRVβ谱系利用特点[J].现代临床医学生物工程学杂志,2004,10(4):283-286. 被引量:6
  • 3陈少华,李扬秋,杨力建,耿素霞.急性早幼粒细胞白血病患者胸腺近期输出功能情况[J].肿瘤研究与临床,2005,17(3):151-152. 被引量:2
  • 4[1]Hayashi K, Yonamine K, Masuko Hongo K, et al. Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor infiltrating T cells in humans [J]. Gynecol Oncol, 1999, 74 (1): 86 - 92.
  • 5[2]Puisieux I, Even J, Pannetier C, et al. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas [ J ].J Immunol, 1994, 153 (6): 2 807 - 2 818.
  • 6[5]Friedman TM, Gilbert M, Briggs C, et al. Repertoire analysis of CD8 + T cell responses to minor histocompatibility antigens involved in graft-versus-host disease [J]. J Immunol,1998, 161 (1): 41-48.
  • 7[6]Leshem B, Doffman Y, Kedar E. Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies [J]. Cancer Immunol Immunother, 1999,48 (4): 179- 188.
  • 8[7]Mutis T, Schrama E, van-Luxemburg Heijs SA, et al. HLA class Ⅱ restricted T cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells [J]. Blood, 1997, 90 (3): 1 083 - 1 090.
  • 9[8]Maccalli C,Farina C, Sensi M, et al. TCR beta-chain variable region driven selection and massive expansion of HLA * 0201+ class Ⅰ restricted antitumor CTL lines from HLA-A melanoma patients [ J ]. J Immunol, 1997, 158 (12):5 902 - 5 913.
  • 10[9]Semino C, Cilli M, Ratto GB, et al. Limiting dilution analysis of peripheral blood lymphocytes reacting with non-smallcell lung cancer: Functionally heterogeneous effectors efficiently lyse autologous cancer cells [J]. Lung Cancer, 1998,21 (1): 27-36.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部